Neonatal vaccination refers to the administration of vaccines to infants within the first month of life, aiming to provide early protection against infectious diseases. While some vaccines are given shortly after birth, others are scheduled in subsequent weeks, following a carefully designed immunization schedule. Common neonatal vaccines include those targeting hepatitis B, which is often administered shortly after birth to prevent perinatal transmission. Additionally, vaccines against tuberculosis, polio, and other diseases are typically initiated in the first few weeks of life. Neonatal vaccination is crucial as it establishes early immunity in infants who are particularly vulnerable to severe infections. It also contributes to the concept of "herd immunity," helping protect those who are unable to receive vaccinations due to medical reasons. Ensuring high vaccination coverage in neonates is a public health priority, as it prevents the spread of infectious diseases and minimizes the risk of outbreaks. Neonatal vaccination programs are continuously updated to incorporate new vaccines and enhance protection against a broader range of pathogens, contributing to improved global child health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom